ColoCam DX-FIT DNA

ColoCam DX - FIT DNA

Colorectal cancer begins when cells in the intestine undergo genetic mutations. Tumor cells shed into the intestines. Stool samples can be examined for tumor DNA using PCR technology.
Polymerase chain reaction (PCR) is used to rapidly make millions to billions of copies of a specific DNA sample and only requires a very small sample of DNA to amplify it large enough for detailed study.
ColoCam DX^® utilizes proprietary methods to analyse the cell DNA for specific tumor markers.
ColoCam DX^® is designed to detect tumor DNA and detect 95% of colorectal cancer cases – often in the earliest stages of the disease.*
Ease-of-use drives ongoing patient adherence as the ColoCam DX^® method requires very small samples compared to screening method.